TY - JOUR
T1 - The role of echocardiography in sports cardiology
T2 - An expert opinion statement of the Italian Society of Sports Cardiology (SIC sport)
AU - Cavarretta, Elena
AU - D'Ascenzi, Flavio
AU - Bianco, Massimiliano
AU - Castelletti, Silvia
AU - Cavigli, Luna
AU - Cecchi, Franco
AU - D'Andrea, Antonello
AU - De Luca, Antonio
AU - Di Salvo, Giovanni
AU - Nistri, Stefano
AU - Palamà, Zefferino
AU - Palmieri, Vincenzo
AU - Ricci, Fabrizio
AU - Sinagra, Gianfranco
AU - Zorzi, Alessandro
AU - Biffi, Alessandro
AU - Pelliccia, Antonio
AU - Romano, Silvio
AU - Dello Russo, Antonio
AU - Zeppilli, Paolo
AU - Patrizi, Giampiero
AU - Sciarra, Luigi
PY - 2024
Y1 - 2024
N2 - Transthoracic echocardiography (TTE) is routinely required during pre-participation screening in the presence of symptoms, family history of sudden cardiac death or cardiomyopathies <40-year-old, murmurs, abnormal ECG findings or in the follow-up of athletes with a history of cardiovascular disease (CVD). TTE is a cost-effective first-line imaging modality to evaluate the cardiac remodeling due to long-term, intense training, previously known as the athlete's heart, and to rule out the presence of conditions at risk of sudden cardiac death, including cardiomyopathies, coronary artery anomalies, congenital, aortic and heart valve diseases. Moreover, TTE is useful for distinguishing physiological cardiac adaptations during intense exercise from pathological behavior due to an underlying CVD. In this expert opinion statement endorsed by the Italian Society of Sports Cardiology, we discussed common clinical scenarios where a TTE is required and conditions falling in the grey zone between the athlete's heart and underlying cardiomyopathies or other CVD. In addition, we propose a minimum dataset that should be included in the report for the most common indications of TTE in sports cardiology clinical practice.
AB - Transthoracic echocardiography (TTE) is routinely required during pre-participation screening in the presence of symptoms, family history of sudden cardiac death or cardiomyopathies <40-year-old, murmurs, abnormal ECG findings or in the follow-up of athletes with a history of cardiovascular disease (CVD). TTE is a cost-effective first-line imaging modality to evaluate the cardiac remodeling due to long-term, intense training, previously known as the athlete's heart, and to rule out the presence of conditions at risk of sudden cardiac death, including cardiomyopathies, coronary artery anomalies, congenital, aortic and heart valve diseases. Moreover, TTE is useful for distinguishing physiological cardiac adaptations during intense exercise from pathological behavior due to an underlying CVD. In this expert opinion statement endorsed by the Italian Society of Sports Cardiology, we discussed common clinical scenarios where a TTE is required and conditions falling in the grey zone between the athlete's heart and underlying cardiomyopathies or other CVD. In addition, we propose a minimum dataset that should be included in the report for the most common indications of TTE in sports cardiology clinical practice.
KW - Athletes
KW - Cardiomyopathy
KW - Echocardiography
KW - Heart valve disease
KW - Pre-participation screening
KW - Sports cardiology
KW - Sudden cardiac death
U2 - 10.1016/j.ijcard.2024.132230
DO - 10.1016/j.ijcard.2024.132230
M3 - Article
C2 - 38852859
AN - SCOPUS:85195661111
SN - 0167-5273
VL - 410
JO - International Journal of Cardiology
JF - International Journal of Cardiology
M1 - 132230
ER -